Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4.

Clinical and experimental medicine - 1 May 2020

Abdel Moneim A, Suleiman H A, Mahmoud B, Mabrouk D, Zaky M Y, Mahmoud B

Abstract excerpt

The achievement of virological response in the treatment of hepatitis C virus (HCV) can improve the extrahepatic manifestations. The present study aimed to investigate the effect of HCV eradication after sofosbuvir/daclatasvir (SOF/DCV) therapy on hematological and inflammatory biomarkers in type 2 diabetic patients infected with HCV genotype 4. Between October 2017 and August 2018, among 145 patients with HCV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbamates
Share to Glycated Hemoglobin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Imidazoles

Share to Interleukin-1beta

Share to Pyrrolidines

Share to Sofosbuvir

Share to Sustained Virologic Response

Share to Valine

Source

Identifiers

PMID: 32076917
DOI: 10.1007/s10238-019-00605-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4.PMID 32076917Read ↗

Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir.Semantic proximity Read ↗

The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents.Semantic proximity Read ↗

Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.Semantic proximity Read ↗

Metabolic changes in chronic hepatitis C patients receiving direct acting antiviralsSemantic proximity Read ↗

The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy.Semantic proximity Read ↗

Risk factors for Type 2 Diabetes Mellitus in Chronic Hepatitis C Virus-Infected Patients: A Retrospective Cohort Study in Southern ChinaSemantic proximity Read ↗

Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs.Semantic proximity Read ↗

Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection.Semantic proximity Read ↗

Prevalence and Genotype Distribution of Hepatitis C Virus Infection among Patients with Type 2 Diabetes Mellitus.Semantic proximity Read ↗

Prevalence of abnormal glycometabolism in treatment-naive patients with hepatitis C virus infection in a Chinese Han population.Semantic proximity Read ↗

Hepatitis C virus genotype distribution in Egyptian diabetic patients: a preliminary study.Semantic proximity Read ↗

Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.